Longs Drug Stores (LDG) Reports September Revenues

Longs Drug Stores Corporation (NYSE: LDG) reported preliminary total revenues of $471.8 million for the five-week period ended September 28, 2006, a 9.5% increase from total revenues of $431.0 million in the comparable period a year ago.

Preliminary September total retail drug store sales were $443.5 million, an increase of 3.6% from $428.2 million in the comparable period last year. Pharmacy sales were 52.2% of total drug store sales compared with 49.7% a year ago. Retail drug store same-store sales increased 1.4% compared with last year. Pharmacy same-store sales increased 5.5% and front-end same-store sales decreased 2.5%.

You May Also Be Interested In

• Polar Power adds two directors with defense and business experience
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'